What is the Ownership and Shareholding Structure of Shrenik Pharma?
In 2017, Shrenik Pharma had a promoter holding of 59.67% and a public holding of 40.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX